FP296
3323
Dr.Mohammed Hyder
| Membership No | Author Name | Mobile | |
|---|---|---|---|
| 3323 | Dr.Mohammed Hyder | hyder220696@gmail.com | 9686419986 |
Cornea, Ocular Surface and External Eye Diseases
Targeting Ocular Fibrosis with Omega-3 Fatty Acids: Experimental and Clinical Evidence
Purpose: To evaluate anti-fibrotic effects of omega-3 fatty acids (O3FA) in ocular epithelial cells and their translational potential for corneal scarring and posterior capsule opacification (PCO). Methods: Human corneal and lens epithelial cells were pretreated with O3FA before TGF-β–induced fibrosis. COL1A1, fibronectin, αSMA, and Snail expression was measured by qPCR. Aqueous humor O3FA levels assessed bioavailability. Fifteen patients with corneal scars received O3FA over 8 months; densitometry tracked opacity. Results: TGF-β upregulated all fibrotic markers; O3FA suppressed them, indicating reduced EMT and ECM remodeling. O3FA was detectable in aqueous humor, suggesting relevance to lens cells. Patients showed a mean 22% densitometry reduction at 8 months. Conclusions: O3FA shows anti-fibrotic activity in ocular epithelial cells and achieves intraocular penetration, suggesting potential as an adjunct strategy for corneal fibrosis, warranting further study in PCO prevention.
| Membership No | Author Name | Mobile | |
|---|---|---|---|
| 865 | Prof.Rohit Shetty | drrohitshetty@yahoo.com | 9611102568 |
| 2590 | Dr.Sunayana N Murthy | sunayananm@gmail.com | 9945042064 |